Search Results

BRD7116 25 mg  | 99.30%

TargetMol

BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.

More Information Supplier Page

BRD7116 10 mg  | 99.30%

TargetMol

BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.

More Information Supplier Page

AMI-1 5 mg  | 99.90%

TargetMol

AMI-1 is an effective and selective Histone Methyltransferase (HMT) inhibitor (IC50: 3.0/8.8 μM, for yeast Hmt1p, and human PRMT1).

More Information Supplier Page

AMI-1 25 mg  | 99.90%

TargetMol

AMI-1 is an effective and selective Histone Methyltransferase (HMT) inhibitor (IC50: 3.0/8.8 μM, for yeast Hmt1p, and human PRMT1).

More Information Supplier Page

RGB-286638 free base 50 mg  | Purity Not Available

TargetMol

RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3/p35-CDK5 respectively; less potent against cyclin H-CDK7 and cyclin D3-CDK6.

More Information Supplier Page

RGB-286638 free base 2 mg  | Purity Not Available

TargetMol

RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3/p35-CDK5 respectively; less potent against cyclin H-CDK7 and cyclin D3-CDK6.

More Information Supplier Page

RGB-286638 free base 10 mg  | Purity Not Available

TargetMol

RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3/p35-CDK5 respectively; less potent against cyclin H-CDK7 and cyclin D3-CDK6.

More Information Supplier Page